Matches in SemOpenAlex for { <https://semopenalex.org/work/W2905409366> ?p ?o ?g. }
- W2905409366 endingPage "e0208774" @default.
- W2905409366 startingPage "e0208774" @default.
- W2905409366 abstract "The development of a substance or inhibitor-based treatment strategy for the prevention of aortic valve stenosis is a challenge and a main focus of medical research in this area. One strategy may be to use the tankyrase inhibitor XAV-939, which leads to Axin stabilisation and subsequent destruction of the β-catenin complex and dephosphorylation of β-catenin. The dephosphorylated active form of β-catenin (non-phospho-β-catenin) then promotes nuclear transcription that leads to osteogenesis. The aims of the present study were to develop an experimental system for inducing in vitro calcification of human aortic valvular interstitial cells (VICs) to investigate the potential anti-calcific effect of XAV-939 and to analyse expression of the Wnt signalling proteins and Sox9, a chondrogenesis regulator, in this model. Calcification of human VIC cultures was induced by cultivation in an osteogenic medium and the effect of co-incubation with 1μM XAV-939 was monitored. Calcification was quantified when mineral deposits were visible in culture and was histologically verified by von Kossa or Alizarin red staining and by IR-spectroscopy. Protein expression of alkaline phosphatase, Axin, β-catenin and Sox9 were quantified by western blotting. In 58% of the VIC preparations, calcification was induced in an osteogenic culture medium and was accompanied by upregulation of alkaline phosphatase. The calcification induction was prevented by the XAV-939 co-treatment and the alkaline phosphatase upregulation was suppressed. As expected, Axin was upregulated, but the levels of active non-phospho-β-catenin were also enhanced. Sox9 was induced during XAV-939 treatment but apparently not as a result of downregulation of β-catenin signalling. XAV-939 was therefore able to prevent calcification of human VIC cultures, and XAV-939 treatment was accompanied by upregulation of active non-phospho-β-catenin. Although XAV-939 does not downregulate active β-catenin, treatment with XAV-939 results in Sox9 upregulation that may prevent the calcification process." @default.
- W2905409366 created "2018-12-22" @default.
- W2905409366 creator A5002652120 @default.
- W2905409366 creator A5010092295 @default.
- W2905409366 creator A5016515871 @default.
- W2905409366 creator A5020294819 @default.
- W2905409366 creator A5026142180 @default.
- W2905409366 creator A5040903767 @default.
- W2905409366 creator A5044182016 @default.
- W2905409366 creator A5044759511 @default.
- W2905409366 creator A5049015853 @default.
- W2905409366 date "2018-12-07" @default.
- W2905409366 modified "2023-10-12" @default.
- W2905409366 title "Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells" @default.
- W2905409366 cites W1912237646 @default.
- W2905409366 cites W1954620535 @default.
- W2905409366 cites W1967483573 @default.
- W2905409366 cites W1983946999 @default.
- W2905409366 cites W1986300386 @default.
- W2905409366 cites W1996611108 @default.
- W2905409366 cites W1996647706 @default.
- W2905409366 cites W2009968012 @default.
- W2905409366 cites W2012669950 @default.
- W2905409366 cites W2014362480 @default.
- W2905409366 cites W2020682286 @default.
- W2905409366 cites W2033524865 @default.
- W2905409366 cites W2040389393 @default.
- W2905409366 cites W2057257265 @default.
- W2905409366 cites W2070274839 @default.
- W2905409366 cites W2079506466 @default.
- W2905409366 cites W2085786505 @default.
- W2905409366 cites W2086149192 @default.
- W2905409366 cites W2097132248 @default.
- W2905409366 cites W2097742069 @default.
- W2905409366 cites W2098560750 @default.
- W2905409366 cites W2099627334 @default.
- W2905409366 cites W2109936279 @default.
- W2905409366 cites W2110838173 @default.
- W2905409366 cites W2113570763 @default.
- W2905409366 cites W2114610684 @default.
- W2905409366 cites W2127141771 @default.
- W2905409366 cites W2131305410 @default.
- W2905409366 cites W2131672223 @default.
- W2905409366 cites W2135977565 @default.
- W2905409366 cites W2148093271 @default.
- W2905409366 cites W2151796223 @default.
- W2905409366 cites W2154274736 @default.
- W2905409366 cites W2156096083 @default.
- W2905409366 cites W2164842316 @default.
- W2905409366 cites W2186166835 @default.
- W2905409366 cites W2188911325 @default.
- W2905409366 cites W2287724317 @default.
- W2905409366 cites W2295832686 @default.
- W2905409366 cites W2326187533 @default.
- W2905409366 cites W2343910187 @default.
- W2905409366 cites W2418808650 @default.
- W2905409366 cites W2524169823 @default.
- W2905409366 cites W2551154296 @default.
- W2905409366 cites W2562922262 @default.
- W2905409366 cites W2746406156 @default.
- W2905409366 cites W2789466138 @default.
- W2905409366 cites W2797846941 @default.
- W2905409366 cites W2894542877 @default.
- W2905409366 cites W988510005 @default.
- W2905409366 doi "https://doi.org/10.1371/journal.pone.0208774" @default.
- W2905409366 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6286025" @default.
- W2905409366 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30532256" @default.
- W2905409366 hasPublicationYear "2018" @default.
- W2905409366 type Work @default.
- W2905409366 sameAs 2905409366 @default.
- W2905409366 citedByCount "14" @default.
- W2905409366 countsByYear W29054093662019 @default.
- W2905409366 countsByYear W29054093662020 @default.
- W2905409366 countsByYear W29054093662021 @default.
- W2905409366 countsByYear W29054093662022 @default.
- W2905409366 countsByYear W29054093662023 @default.
- W2905409366 crossrefType "journal-article" @default.
- W2905409366 hasAuthorship W2905409366A5002652120 @default.
- W2905409366 hasAuthorship W2905409366A5010092295 @default.
- W2905409366 hasAuthorship W2905409366A5016515871 @default.
- W2905409366 hasAuthorship W2905409366A5020294819 @default.
- W2905409366 hasAuthorship W2905409366A5026142180 @default.
- W2905409366 hasAuthorship W2905409366A5040903767 @default.
- W2905409366 hasAuthorship W2905409366A5044182016 @default.
- W2905409366 hasAuthorship W2905409366A5044759511 @default.
- W2905409366 hasAuthorship W2905409366A5049015853 @default.
- W2905409366 hasBestOaLocation W29054093661 @default.
- W2905409366 hasConcept C104317684 @default.
- W2905409366 hasConcept C126322002 @default.
- W2905409366 hasConcept C127561419 @default.
- W2905409366 hasConcept C131075544 @default.
- W2905409366 hasConcept C137620995 @default.
- W2905409366 hasConcept C160160445 @default.
- W2905409366 hasConcept C181199279 @default.
- W2905409366 hasConcept C185592680 @default.
- W2905409366 hasConcept C202751555 @default.
- W2905409366 hasConcept C2780309369 @default.
- W2905409366 hasConcept C55493867 @default.